\-\ Texto\\:\\ \ \(0\)\
\-\ weakness\\ in\\ both\\ upper\\ and\\ lower\\ extremities\\,\\ right\\ greater\\ than\\ left\\.\ \(0\)\
\-\ multiple\\ lesions\\ within\\ the\\ brain\\.\\ the\\ most\\ prominent\\ were\\ in\\ the\\ left\\ frontal\\ and\\ parietal\\ region\\.\\ the\\ lesions\\ were\\ very\\ hyperintense\\ on\\ t2\\,\\ and\\ demonstrated\\ only\\ peripheral\\ enhancement\ \(0\)\
\-\ chondrosarcoma\\ metastatic\\ to\\ brain\ \(0\)\
\-\ given\\ the\\ marked\\ hyperintensity\\ on\\ t2\\ and\\ history\\ of\\ chondrosarcoma\\,\\ this\\ is\\ the\\ most\\ likely\\ diagnosis\\.\\ \\ metastases\\ from\\ other\\ locations\\ could\\ also\\ be\\ in\\ the\\ differential\\.\ \(0\)\
\-\ 55\\ yo\\ woman\\ with\\ history\\ of\\ a\\ resected\\ left\\ lower\\ extremity\\ chondrosarcoma\\.\\ \\ known\\ to\\ have\\ lung\\ metastases\\,\\ she\\ presents\\ now\\ with\\ right\\ upper\\ and\\ lower\\ extremity\\ weakness\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ chondrosarcoma\\:\\ 0\\.3964429747622546\ \(0\)\
\-\ metastases\\:\\ 0\\.23301667618004948\ \(0\)\
\-\ lower\\:\\ 0\\.22092762102499527\ \(0\)\
\-\ weakness\\:\\ 0\\.21035587795028482\ \(0\)\
\-\ extremity\\:\\ 0\\.20759599904021145\ \(0\)\
\-\ the\\:\\ 0\\.20129210678091033\ \(0\)\
\-\ brain\\:\\ 0\\.17968088849407604\ \(0\)\
\-\ t2\\:\\ 0\\.1658258148475608\ \(0\)\
\-\ lesions\\:\\ 0\\.16553289970337362\ \(0\)\
\-\ upper\\:\\ 0\\.1540248490099401\ \(0\)\
\-\ locations\\:\\ 0\\.15071204506940183\ \(0\)\
\-\ most\\:\\ 0\\.15000284170536515\ \(0\)\
\-\ and\\:\\ 0\\.148897229206746\ \(0\)\
\-\ were\\:\\ 0\\.14857346565280127\ \(0\)\
\-\ left\\:\\ 0\\.14748154371575004\ \(0\)\
\-\ hyperintensity\\:\\ 0\\.14371428963329208\ \(0\)\
\-\ resected\\:\\ 0\\.13189117015834853\ \(0\)\
\-\ 55\\:\\ 0\\.12386900933615598\ \(0\)\
\-\ parietal\\:\\ 0\\.11636990563169691\ \(0\)\
\-\ hyperintense\\:\\ 0\\.11463608462452089\ \(0\)\
\-\ prominent\\:\\ 0\\.1135018555282491\ \(0\)\
\-\ history\\:\\ 0\\.11011997446979255\ \(0\)\
\-\ extremities\\:\\ 0\\.10951953988160447\ \(0\)\
\-\ marked\\:\\ 0\\.10899861708747559\ \(0\)\
\-\ in\\:\\ 0\\.10755284657155748\ \(0\)\
\-\ greater\\:\\ 0\\.1061723516521754\ \(0\)\
\-\ could\\:\\ 0\\.1048258237221858\ \(0\)\
\-\ very\\:\\ 0\\.10338178153233117\ \(0\)\
\-\ peripheral\\:\\ 0\\.10305367483711882\ \(0\)\
\-\ given\\:\\ 0\\.09913595963590591\ \(0\)\
\-\ now\\:\\ 0\\.09892745341442596\ \(0\)\
\-\ right\\:\\ 0\\.09555967493157147\ \(0\)\
\-\ differential\\:\\ 0\\.09363845844264676\ \(0\)\
\-\ known\\:\\ 0\\.09330383288262373\ \(0\)\
\-\ frontal\\:\\ 0\\.09275578838923573\ \(0\)\
\-\ only\\:\\ 0\\.09003440957933839\ \(0\)\
\-\ yo\\:\\ 0\\.09003440957933839\ \(0\)\
\-\ demonstrated\\:\\ 0\\.08856874199939078\ \(0\)\
\-\ lung\\:\\ 0\\.08766636534557842\ \(0\)\
\-\ on\\:\\ 0\\.0870499557167978\ \(0\)\
\-\ region\\:\\ 0\\.08620263191510609\ \(0\)\
\-\ likely\\:\\ 0\\.08611911494505325\ \(0\)\
\-\ she\\:\\ 0\\.08578778087880513\ \(0\)\
\-\ enhancement\\:\\ 0\\.08294965486361716\ \(0\)\
\-\ than\\:\\ 0\\.0816942722485101\ \(0\)\
\-\ both\\:\\ 0\\.08036518554682404\ \(0\)\
\-\ metastatic\\:\\ 0\\.07903945815448725\ \(0\)\
\-\ woman\\:\\ 0\\.07505517376750002\ \(0\)\
\-\ other\\:\\ 0\\.07484084492799253\ \(0\)\
\-\ diagnosis\\:\\ 0\\.0747078069142254\ \(0\)\
\-\ to\\:\\ 0\\.07205655995322717\ \(0\)\
\-\ have\\:\\ 0\\.07199297388783976\ \(0\)\
\-\ multiple\\:\\ 0\\.07048941727603748\ \(0\)\
\-\ presents\\:\\ 0\\.0693263942085741\ \(0\)\
\-\ also\\:\\ 0\\.06778721403984844\ \(0\)\
\-\ within\\:\\ 0\\.06637458061401351\ \(0\)\
\-\ be\\:\\ 0\\.05846139076015474\ \(0\)\
\-\ from\\:\\ 0\\.05723607118059069\ \(0\)\
\-\ with\\:\\ 0\\.05643874456667227\ \(0\)\
\-\ of\\:\\ 0\\.05640504256717896\ \(0\)\
\-\ this\\:\\ 0\\.04952025235525872\ \(0\)\
\-\ is\\:\\ 0\\.03946666708953622\ \(0\)\
